Amycretin vs Semaglutide

Amycretin is an experimental drug that combines two hormone signals (amylin and GLP-1) to help control blood sugar and appetite, but it is not yet approved by the FDA for any use. Semaglutide, sold under brand names like Ozempic and Wegovy, is an FDA-approved GLP-1 drug used to treat type 2 diabetes, obesity, chronic kidney disease, and reduce cardiovascular risk; it comes in injectable and oral forms.

AI summary of the sources below.